Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy
by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and
Updated on: January 13,2024
12
Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy
by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and
Updated on:January 13,2024
12
